Half Year 2025 Life Healthcare Group Holdings Ltd Earnings Call Transcript
Key Points
- Life Healthcare Group Holdings Ltd (LTGHY) reported an overall revenue growth of 8.1% during a challenging period.
- The company's hospitals EBITDA increased by 10.2%, indicating strong operational performance.
- Normalized earnings per share rose by 9.1%, reflecting improved profitability.
- An interim dividend was declared, up 10.5% to ZAR0.21 per share, continuing positive cash returns to shareholders.
- The company successfully added 20 ICU beds and plans to add another 62 beds in the second half, demonstrating expansion efforts.
- Life Nkanyisa faced contractual challenges, resulting in the loss of some contracts.
- The company had to recognize liabilities of ZAR2.9 billion related to the Life Molecular Imaging transaction before realizing profits.
- The incentive charge increased from ZAR128 million to ZAR182 million, impacting comparability with the previous year.
- Despite improvements, the occupancy rate of 68.3% is still short of the targeted 70%.
- The healthcare services segment experienced a loss of contracts, affecting revenue growth in that area.
Good day, ladies and gentlemen, and welcome to the Life Healthcare unaudited group interim results for the six months ended 31 March, 2025, and the cash dividend declaration. (Operator Instructions) Please note this conference is being recorded.
I'd now like to turn the conference over to the CEO, Mr. Peter Wharton-Hood. Please go ahead, sir.
Good morning, ladies and gentlemen, and welcome to our results presentation. I'm joined in Johannesburg with my two colleagues, Pieter van der Westhuizen and Adam Pyle. And we'll jump straight into the review of the six-month performance.
I think in the highlight sense, we could move straight to the PPD growth, which we feel we predicted and proud to report, was up 2% during the period under review. Occupancy is on track to get to the 70% that we're also targeting. Overall revenue growth of 8.1% during what was quite a difficult period.
Our hospitals EBITDA up [10.2%]. Normalized
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
